 Alexander Kaizer
Concepts (454)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 10 | 2024 | 1120 | 1.890 |
Why?
| | Bayes Theorem | 12 | 2025 | 413 | 1.820 |
Why?
| | Medical Futility | 2 | 2024 | 27 | 1.620 |
Why?
| | Models, Statistical | 5 | 2024 | 665 | 1.180 |
Why?
| | Atrioventricular Block | 4 | 2022 | 37 | 1.170 |
Why?
| | Gastroesophageal Reflux | 8 | 2024 | 242 | 1.090 |
Why?
| | Heart Rate, Fetal | 2 | 2023 | 24 | 0.980 |
Why?
| | Long QT Syndrome | 2 | 2023 | 67 | 0.910 |
Why?
| | Data Interpretation, Statistical | 3 | 2024 | 364 | 0.860 |
Why?
| | Computer Simulation | 4 | 2024 | 995 | 0.790 |
Why?
| | Laryngopharyngeal Reflux | 4 | 2024 | 15 | 0.780 |
Why?
| | Ritonavir | 1 | 2022 | 75 | 0.750 |
Why?
| | Neoplasms | 5 | 2024 | 2687 | 0.730 |
Why?
| | Bariatric Surgery | 6 | 2020 | 217 | 0.730 |
Why?
| | Weight Loss | 8 | 2023 | 783 | 0.710 |
Why?
| | Obesity, Morbid | 6 | 2020 | 271 | 0.710 |
Why?
| | Tobacco Products | 2 | 2020 | 131 | 0.700 |
Why?
| | Humans | 111 | 2025 | 138972 | 0.680 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 239 | 0.660 |
Why?
| | Neostigmine | 1 | 2020 | 16 | 0.650 |
Why?
| | Pediatric Obesity | 8 | 2020 | 597 | 0.610 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1034 | 0.610 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 28 | 0.590 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 8 | 0.590 |
Why?
| | Data Collection | 1 | 2021 | 660 | 0.580 |
Why?
| | Anaphylaxis | 1 | 2020 | 107 | 0.580 |
Why?
| | Biostatistics | 1 | 2018 | 18 | 0.560 |
Why?
| | Therapeutics | 1 | 2018 | 14 | 0.560 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 28 | 0.530 |
Why?
| | Retrospective Studies | 33 | 2025 | 15901 | 0.510 |
Why?
| | Clinical Protocols | 1 | 2018 | 273 | 0.500 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 68 | 0.490 |
Why?
| | Fetal Diseases | 4 | 2023 | 177 | 0.480 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 245 | 0.480 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 1092 | 0.470 |
Why?
| | Ixodidae | 1 | 2015 | 7 | 0.470 |
Why?
| | Prospective Studies | 22 | 2025 | 7661 | 0.470 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 10 | 0.450 |
Why?
| | Manometry | 7 | 2023 | 96 | 0.440 |
Why?
| | Treatment Outcome | 18 | 2025 | 10921 | 0.440 |
Why?
| | Larva | 1 | 2015 | 234 | 0.430 |
Why?
| | Pepsin A | 3 | 2023 | 19 | 0.420 |
Why?
| | Sample Size | 3 | 2024 | 127 | 0.410 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 57 | 0.390 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 17 | 0.390 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 2 | 0.380 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 23 | 0.380 |
Why?
| | Female | 52 | 2025 | 74016 | 0.370 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 108 | 0.360 |
Why?
| | Injections, Spinal | 3 | 2025 | 108 | 0.360 |
Why?
| | Information Dissemination | 2 | 2024 | 223 | 0.350 |
Why?
| | Obesity | 5 | 2023 | 2994 | 0.340 |
Why?
| | Enteral Nutrition | 2 | 2025 | 202 | 0.340 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 324 | 0.330 |
Why?
| | Nerve Block | 3 | 2021 | 90 | 0.320 |
Why?
| | Anesthetics | 2 | 2022 | 98 | 0.320 |
Why?
| | Body Contouring | 2 | 2020 | 9 | 0.320 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1522 | 0.320 |
Why?
| | Probability | 4 | 2023 | 308 | 0.310 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 15 | 0.310 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 40 | 0.310 |
Why?
| | Pain Management | 2 | 2025 | 389 | 0.310 |
Why?
| | Adult | 30 | 2025 | 38393 | 0.310 |
Why?
| | Male | 43 | 2025 | 68250 | 0.280 |
Why?
| | Esophagus | 2 | 2020 | 257 | 0.280 |
Why?
| | Pregnancy | 8 | 2023 | 6870 | 0.260 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2024 | 28 | 0.260 |
Why?
| | Surgeons | 2 | 2021 | 327 | 0.260 |
Why?
| | Anesthetics, Local | 3 | 2022 | 98 | 0.250 |
Why?
| | Pain, Postoperative | 5 | 2022 | 309 | 0.250 |
Why?
| | Nicotine | 2 | 2020 | 347 | 0.250 |
Why?
| | Child | 19 | 2025 | 21936 | 0.240 |
Why?
| | After-Hours Care | 1 | 2025 | 17 | 0.240 |
Why?
| | Cough | 2 | 2024 | 125 | 0.240 |
Why?
| | Fractures, Multiple | 1 | 2025 | 6 | 0.230 |
Why?
| | Pierre Robin Syndrome | 1 | 2025 | 9 | 0.230 |
Why?
| | Bupivacaine | 2 | 2022 | 38 | 0.230 |
Why?
| | Micrognathism | 1 | 2025 | 18 | 0.230 |
Why?
| | Osteogenesis, Distraction | 1 | 2025 | 18 | 0.230 |
Why?
| | Infant | 9 | 2025 | 9577 | 0.230 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 428 | 0.220 |
Why?
| | Mandible | 1 | 2025 | 68 | 0.220 |
Why?
| | Hearing Aids | 2 | 2023 | 76 | 0.220 |
Why?
| | Airway Management | 1 | 2025 | 64 | 0.220 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 228 | 0.220 |
Why?
| | Cancer Pain | 1 | 2025 | 35 | 0.220 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 16 | 0.220 |
Why?
| | Laparoscopy | 2 | 2020 | 452 | 0.220 |
Why?
| | Incidence | 6 | 2023 | 2830 | 0.220 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 416 | 0.220 |
Why?
| | Biometry | 1 | 2024 | 69 | 0.210 |
Why?
| | Body Weight | 2 | 2019 | 996 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2024 | 21 | 0.210 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 6 | 0.210 |
Why?
| | Blood Transfusion | 2 | 2024 | 377 | 0.210 |
Why?
| | Radiation Dosage | 1 | 2025 | 188 | 0.200 |
Why?
| | Myotomy | 1 | 2023 | 15 | 0.200 |
Why?
| | Atrial Flutter | 1 | 2023 | 31 | 0.200 |
Why?
| | Aged | 17 | 2025 | 24172 | 0.200 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 43 | 0.200 |
Why?
| | Postoperative Care | 1 | 2025 | 273 | 0.200 |
Why?
| | Airway Obstruction | 1 | 2025 | 164 | 0.200 |
Why?
| | Intestinal Atresia | 1 | 2023 | 15 | 0.200 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 67 | 0.200 |
Why?
| | Predictive Value of Tests | 3 | 2024 | 2030 | 0.200 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 27 | 0.200 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 188 | 0.200 |
Why?
| | Lopinavir | 1 | 2022 | 31 | 0.200 |
Why?
| | Intubation, Intratracheal | 1 | 2025 | 279 | 0.190 |
Why?
| | Middle Aged | 19 | 2025 | 33782 | 0.190 |
Why?
| | Heart Arrest | 2 | 2024 | 383 | 0.190 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.190 |
Why?
| | Lidocaine | 1 | 2023 | 53 | 0.190 |
Why?
| | Infant, Newborn | 6 | 2025 | 6158 | 0.190 |
Why?
| | Point-of-Care Systems | 1 | 2024 | 184 | 0.190 |
Why?
| | Neutropenia | 1 | 2023 | 157 | 0.190 |
Why?
| | Fetal Heart | 2 | 2019 | 56 | 0.190 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 19 | 0.190 |
Why?
| | Triage | 1 | 2024 | 241 | 0.190 |
Why?
| | Electromyography | 1 | 2024 | 400 | 0.180 |
Why?
| | Tympanoplasty | 1 | 2022 | 8 | 0.180 |
Why?
| | Adolescent | 18 | 2025 | 21581 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 77 | 0.180 |
Why?
| | Diaphragm | 2 | 2022 | 43 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2025 | 311 | 0.180 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 17 | 0.180 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 56 | 0.180 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.180 |
Why?
| | Tremor | 1 | 2022 | 97 | 0.180 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2021 | 21 | 0.180 |
Why?
| | Lung | 3 | 2024 | 4103 | 0.180 |
Why?
| | Funnel Chest | 1 | 2021 | 24 | 0.180 |
Why?
| | Psychological Trauma | 1 | 2022 | 54 | 0.180 |
Why?
| | Vitamin D | 1 | 2025 | 399 | 0.180 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 71 | 0.180 |
Why?
| | Telemedicine | 2 | 2021 | 876 | 0.180 |
Why?
| | Nose Neoplasms | 1 | 2021 | 24 | 0.180 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 26 | 0.180 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.180 |
Why?
| | Prostate | 1 | 2022 | 173 | 0.170 |
Why?
| | Postoperative Complications | 4 | 2021 | 2716 | 0.170 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 67 | 0.170 |
Why?
| | Medicare Part D | 1 | 2021 | 25 | 0.170 |
Why?
| | Congenital Microtia | 1 | 2020 | 7 | 0.170 |
Why?
| | Patient Handoff | 1 | 2021 | 38 | 0.170 |
Why?
| | Tumor Burden | 1 | 2022 | 307 | 0.170 |
Why?
| | Fetus | 2 | 2023 | 800 | 0.170 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 39 | 0.170 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 188 | 0.170 |
Why?
| | Specialties, Surgical | 1 | 2022 | 76 | 0.170 |
Why?
| | Cystectomy | 1 | 2021 | 40 | 0.170 |
Why?
| | Hepatectomy | 1 | 2023 | 240 | 0.170 |
Why?
| | Risk Factors | 11 | 2025 | 10385 | 0.170 |
Why?
| | Ear | 1 | 2020 | 33 | 0.170 |
Why?
| | Electrocardiography | 1 | 2023 | 610 | 0.160 |
Why?
| | Bias | 1 | 2021 | 225 | 0.160 |
Why?
| | Shock | 1 | 2021 | 101 | 0.160 |
Why?
| | Ocular Hypertension | 1 | 2021 | 67 | 0.160 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2058 | 0.160 |
Why?
| | Drug Costs | 1 | 2021 | 110 | 0.160 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 231 | 0.160 |
Why?
| | Prevalence | 3 | 2023 | 2745 | 0.160 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 93 | 0.160 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.160 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 105 | 0.160 |
Why?
| | Hearing Loss | 1 | 2023 | 219 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 105 | 0.160 |
Why?
| | Carcinoma | 1 | 2021 | 230 | 0.160 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 101 | 0.160 |
Why?
| | Cochlear Implantation | 1 | 2021 | 75 | 0.160 |
Why?
| | Tracheostomy | 1 | 2021 | 133 | 0.160 |
Why?
| | Cochlear Implants | 1 | 2021 | 89 | 0.150 |
Why?
| | Speech Perception | 1 | 2021 | 82 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 3 | 2025 | 2697 | 0.150 |
Why?
| | Exercise | 3 | 2020 | 2086 | 0.150 |
Why?
| | Hyperplasia | 1 | 2020 | 176 | 0.150 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2533 | 0.150 |
Why?
| | Spine | 1 | 2021 | 179 | 0.150 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 56 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.150 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 90 | 0.150 |
Why?
| | Drug Prescriptions | 1 | 2021 | 260 | 0.150 |
Why?
| | Medically Underserved Area | 1 | 2019 | 90 | 0.150 |
Why?
| | Cardiotocography | 1 | 2018 | 5 | 0.150 |
Why?
| | Stillbirth | 1 | 2019 | 73 | 0.150 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 254 | 0.150 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 9 | 0.150 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 104 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 71 | 0.150 |
Why?
| | Baths | 1 | 2018 | 14 | 0.150 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.150 |
Why?
| | Genotype | 1 | 2023 | 1849 | 0.140 |
Why?
| | Outpatients | 1 | 2022 | 419 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 397 | 0.140 |
Why?
| | Depressive Disorder, Major | 1 | 2022 | 374 | 0.140 |
Why?
| | Anesthesia | 1 | 2022 | 245 | 0.140 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 23 | 0.140 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 40 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4316 | 0.140 |
Why?
| | Nutritional Status | 1 | 2021 | 353 | 0.140 |
Why?
| | Africa, Western | 1 | 2018 | 21 | 0.140 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2018 | 21 | 0.140 |
Why?
| | Gastroenterology | 1 | 2020 | 176 | 0.140 |
Why?
| | Perioperative Care | 1 | 2020 | 213 | 0.140 |
Why?
| | Cannabinoids | 1 | 2020 | 168 | 0.140 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1811 | 0.140 |
Why?
| | Phenotype | 2 | 2023 | 3143 | 0.140 |
Why?
| | Glaucoma | 1 | 2021 | 241 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 576 | 0.140 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5530 | 0.140 |
Why?
| | Barrett Esophagus | 1 | 2020 | 154 | 0.140 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 45 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 286 | 0.130 |
Why?
| | Body Mass Index | 4 | 2023 | 2390 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2019 | 169 | 0.130 |
Why?
| | Hypoxia | 2 | 2025 | 1148 | 0.130 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.130 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 78 | 0.130 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 137 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 127 | 0.130 |
Why?
| | Serogroup | 1 | 2017 | 45 | 0.130 |
Why?
| | Disinfection | 1 | 2018 | 126 | 0.130 |
Why?
| | Time Factors | 6 | 2025 | 6869 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 249 | 0.130 |
Why?
| | Phentermine | 1 | 2016 | 12 | 0.130 |
Why?
| | Child, Preschool | 8 | 2025 | 11158 | 0.130 |
Why?
| | Biomarkers, Tumor | 1 | 2023 | 1229 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 638 | 0.130 |
Why?
| | Swine | 3 | 2024 | 800 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2018 | 103 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2021 | 670 | 0.120 |
Why?
| | Burns | 1 | 2021 | 340 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 573 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2022 | 733 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2022 | 557 | 0.120 |
Why?
| | Fructose | 1 | 2016 | 113 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 242 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 427 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 156 | 0.120 |
Why?
| | Spinal Cord | 3 | 2024 | 373 | 0.120 |
Why?
| | Gestational Age | 4 | 2019 | 918 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 556 | 0.120 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 110 | 0.120 |
Why?
| | Body Composition | 1 | 2019 | 695 | 0.120 |
Why?
| | Internal Medicine | 1 | 2018 | 270 | 0.120 |
Why?
| | United States | 9 | 2024 | 15074 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2022 | 707 | 0.120 |
Why?
| | Mentoring | 1 | 2018 | 150 | 0.120 |
Why?
| | Adiposity | 2 | 2019 | 522 | 0.120 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 234 | 0.120 |
Why?
| | Missouri | 1 | 2015 | 60 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3313 | 0.120 |
Why?
| | Pain Measurement | 3 | 2025 | 549 | 0.120 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 169 | 0.110 |
Why?
| | Faculty, Medical | 1 | 2018 | 290 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 782 | 0.110 |
Why?
| | Meals | 1 | 2016 | 132 | 0.110 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 313 | 0.110 |
Why?
| | Suicide | 1 | 2022 | 663 | 0.110 |
Why?
| | Forests | 1 | 2015 | 59 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 421 | 0.110 |
Why?
| | Length of Stay | 4 | 2021 | 1237 | 0.110 |
Why?
| | Critical Illness | 1 | 2021 | 836 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 661 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 392 | 0.110 |
Why?
| | Disease Outbreaks | 1 | 2018 | 416 | 0.110 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 5884 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 849 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2022 | 834 | 0.110 |
Why?
| | Pilot Projects | 4 | 2021 | 1765 | 0.110 |
Why?
| | Veterans | 2 | 2022 | 1481 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1249 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2018 | 538 | 0.100 |
Why?
| | Feeding Behavior | 1 | 2019 | 685 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 935 | 0.100 |
Why?
| | Mothers | 1 | 2019 | 765 | 0.100 |
Why?
| | Cannabis | 1 | 2020 | 500 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 52 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 2962 | 0.100 |
Why?
| | Muscle Spasticity | 2 | 2023 | 61 | 0.100 |
Why?
| | Medicare | 3 | 2024 | 792 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 546 | 0.100 |
Why?
| | Minnesota | 3 | 2018 | 167 | 0.100 |
Why?
| | Animals | 5 | 2024 | 37243 | 0.100 |
Why?
| | Clinical Competence | 1 | 2020 | 1149 | 0.100 |
Why?
| | Seasons | 1 | 2015 | 538 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 930 | 0.090 |
Why?
| | Electric Impedance | 2 | 2023 | 111 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2228 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 850 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1222 | 0.090 |
Why?
| | Mental Health | 1 | 2018 | 742 | 0.090 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1183 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 91 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1179 | 0.090 |
Why?
| | ROC Curve | 2 | 2024 | 564 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 557 | 0.090 |
Why?
| | Intensive Care Units | 3 | 2021 | 871 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2152 | 0.080 |
Why?
| | Anxiety | 1 | 2018 | 1070 | 0.080 |
Why?
| | Cohort Studies | 4 | 2021 | 5744 | 0.080 |
Why?
| | Saliva | 2 | 2023 | 240 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 573 | 0.080 |
Why?
| | Operating Rooms | 2 | 2022 | 142 | 0.080 |
Why?
| | Cesarean Section | 2 | 2023 | 211 | 0.080 |
Why?
| | Operative Time | 2 | 2022 | 149 | 0.080 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 169 | 0.080 |
Why?
| | Medical Oncology | 2 | 2022 | 304 | 0.080 |
Why?
| | Hemodynamics | 2 | 2024 | 1093 | 0.070 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 143 | 0.070 |
Why?
| | Prognosis | 3 | 2023 | 3995 | 0.070 |
Why?
| | Depression | 1 | 2018 | 1470 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1939 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5152 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 980 | 0.060 |
Why?
| | Registries | 2 | 2025 | 2081 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 1730 | 0.060 |
Why?
| | Mice | 1 | 2022 | 17828 | 0.060 |
Why?
| | Decompression | 1 | 2024 | 3 | 0.060 |
Why?
| | False Negative Reactions | 1 | 2024 | 60 | 0.060 |
Why?
| | Uncertainty | 1 | 2025 | 130 | 0.050 |
Why?
| | Caregivers | 2 | 2023 | 904 | 0.050 |
Why?
| | Disease Progression | 2 | 2024 | 2752 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2024 | 65 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 115 | 0.050 |
Why?
| | Ventricular Fibrillation | 1 | 2024 | 60 | 0.050 |
Why?
| | Quality Control | 1 | 2024 | 173 | 0.050 |
Why?
| | Neck | 1 | 2024 | 104 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2024 | 30 | 0.050 |
Why?
| | Patient Positioning | 1 | 2024 | 69 | 0.050 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.050 |
Why?
| | Larynx | 1 | 2024 | 62 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 26 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 14 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 55 | 0.050 |
Why?
| | Epinephrine | 1 | 2023 | 145 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 111 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3574 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1645 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2024 | 117 | 0.050 |
Why?
| | Edema | 1 | 2023 | 129 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2850 | 0.050 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 237 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 105 | 0.050 |
Why?
| | Rotator Cuff | 1 | 2022 | 46 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 7 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 124 | 0.040 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.040 |
Why?
| | Goals | 1 | 2023 | 177 | 0.040 |
Why?
| | Motor Skills | 1 | 2022 | 100 | 0.040 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 186 | 0.040 |
Why?
| | Malawi | 1 | 2021 | 53 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2022 | 143 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 214 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 517 | 0.040 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 102 | 0.040 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 24 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 193 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 748 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 187 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 65 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 13 | 0.040 |
Why?
| | Noise | 1 | 2021 | 65 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 268 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3466 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 2 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 7 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 77 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 70 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 140 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 8 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 579 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 56 | 0.040 |
Why?
| | Iron | 1 | 2022 | 324 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 20 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 4095 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 216 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 528 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 459 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 51 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4543 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 427 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 546 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 747 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 313 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 429 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 81 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 13 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 134 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 306 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 769 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 24 | 0.040 |
Why?
| | Patient Care Bundles | 1 | 2018 | 24 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 165 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2018 | 91 | 0.040 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 14 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 272 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 225 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 126 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2018 | 57 | 0.030 |
Why?
| | Staff Development | 1 | 2018 | 58 | 0.030 |
Why?
| | Carrier State | 1 | 2018 | 70 | 0.030 |
Why?
| | Mortality | 1 | 2020 | 360 | 0.030 |
Why?
| | Catheters | 1 | 2018 | 73 | 0.030 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 229 | 0.030 |
Why?
| | Chronic Disease | 1 | 2024 | 1804 | 0.030 |
Why?
| | Comorbidity | 1 | 2022 | 1657 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 689 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 320 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 13371 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 355 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 19 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 328 | 0.030 |
Why?
| | Africa | 1 | 2017 | 118 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 54 | 0.030 |
Why?
| | Risk | 1 | 2019 | 913 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 310 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 213 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 609 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 920 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1355 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 91 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 515 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1312 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 355 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 366 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 343 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 963 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 263 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 109 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 608 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 267 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 216 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1409 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1934 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1807 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2016 | 273 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 387 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 558 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2114 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2093 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1215 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1734 | 0.020 |
Why?
| | Primary Health Care | 1 | 2023 | 1776 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2016 | 1949 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 993 | 0.020 |
Why?
| | Parents | 1 | 2019 | 1423 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1285 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2447 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|